Concepedia
Statistics
Publications
16
Citations
1.1K
H-Index
14
Active since
1986
Affiliations
Boehringer Ingelheim (United States)(Current)
University of Connecticut
Baystate Medical Center
University of Massachusetts Chan Medical School
Boehringer Ingelheim (Germany)
Michael Lamson is an author at Boehringer Ingelheim (United States) specializing in medicine, pharmacotherapy, and pharmacology.
Top concepts
MedicinePharmacologyPharmacotherapyPharmacokineticsNeuropharmacologyMolecular PharmacologyPharmacokinetic ModelingHivAddictionBiophysics
Publications per year
1986–2022
Disposition and Biotransformation of the Antiretroviral Drug Nevirapine in Humans
Paul Riska, Michael Lamson, Thomas R. MacGregor et al. · Drug Metabolism and Disposition · 1999 · 221 citations
Combination Treatment with Zidovudine, Didanosine, and Nevirapine in Infants with Human Immunodeficiency Virus Type 1 Infection
Katherine Luzuriaga, Yvonne J. Bryson, Paul Krogstad et al. · New England Journal of Medicine · 1997 · 214 citations
Antiviral Effect and Pharmacokinetic Interaction between Nevirapine and Indinavir in Persons Infected with Human Immunodeficiency Virus Type 1
Robert L. Murphy, Jean‐Pierre Sommadossi, Michael Lamson et al. · The Journal of Infectious Diseases · 1999 · 118 citations
Pharmacokinetic Interaction Between Nevirapine and Ethinyl Estradiol/Norethindrone When Administered Concurrently to HIV-Infected Women
Donna Mildvan, Robert Yarrish, Ann Marshak et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2002 · 86 citations
Pharmacokinetics, Safety, and Activity of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Children
Katherine Luzuriaga, Yvonne J. Bryson, George McSherry et al. · The Journal of Infectious Diseases · 1996 · 78 citations
1–5 of 16